Your session is about to expire
← Back to Search
Emollient
Control group (no moisturizers) for Eczema (BEEP Trial)
N/A
Waitlist Available
Led By Eric L. Simpson, M.D., M.C.R.
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Approved for 10 Other Conditions
No Placebo-Only Group
Summary
The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.
Eligible Conditions
- Eczema
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of families willing to be randomized.
Awards & Highlights
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Control group (no moisturizers)Active Control1 Intervention
This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.
Group II: Intervention (moisturizer group)Active Control3 Interventions
One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
1,003 Previous Clinical Trials
7,412,344 Total Patients Enrolled
8 Trials studying Eczema
1,484 Patients Enrolled for Eczema
Eric L. Simpson, M.D., M.C.R.Principal InvestigatorOregon Health and Science University
Share this study with friends
Copy Link
Messenger